|
FORM 8.3 Amendment - this form replaces RNS number 6302W published at 15:25 on 28/09/2026, changes made to section 2A,3B |
|||||||
|
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY |
|||||||
|
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR |
|||||||
|
MORE |
|||||||
|
Rule 8.3 of the Takeover Code (the "Code") |
|||||||
|
1. |
KEY INFORMATION |
||||||
|
(a) |
Full name of discloser: |
Barclays PLC. |
|||||
|
(b) |
Owner or controller of interest and short |
||||||
|
positions disclosed, if different from 1(a): |
|||||||
|
(c) |
Name of offeror/offeree in relation to whose |
ADVANCED MEDICAL SOLUTIONS GROUP PLC |
|||||
|
relevant securities this form relates: |
|||||||
|
(d) |
If an exempt fund manager connected with an |
||||||
|
offeror/offeree, state this and specify identity of |
|||||||
|
offeror/offeree: |
|||||||
|
(e) |
Date position held/dealing undertaken: |
25 Sep 2026 |
|||||
|
(f) |
In addition to the company in 1(c) above, is the discloser making |
NO |
|||||
|
disclosures in respect of any other party to the offer? |
|||||||
|
2. |
POSITIONS OF THE PERSON MAKING THE DISCLOSURE |
||||||
|
(a) |
Interests and short positions in the relevant securities of the offeror or offeree |
||||||
|
to which the disclosure relates following the dealing(if any) |
|||||||
|
Class of relevant security: |
5p ordinary |
||||||
|
Interests |
Short Positions |
||||||
|
Number |
(%) |
Number |
(%) |
||||
|
(1) |
Relevant securities owned |
||||||
|
and/or controlled: |
6,874,748 |
3.11% |
1,145,907 |
0.52% |
|||
|
(2) |
Cash-settled derivatives: |
||||||
|
1,141,253 |
0.52% |
6,866,653 |
3.11% |
||||
|
(3) |
Stock-settled derivatives (including options) |
||||||
|
and agreements to purchase/sell: |
0 |
0.00% |
0 |
0.00% |
|||
|
TOTAL: |
8,016,001 |
3.63% |
8,012,560 |
3.63% |
|||
|
(b) |
Rights to subscribe for new securities (including directors and other executive |
||||||
|
options) |
|||||||
|
Class of relevant security in relation to |
|||||||
|
which subscription right exists |
|||||||
|
Details, including nature of the rights |
|||||||
|
concerned and relevant percentages: |
|||||||
|
3. |
DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE |
||||||
|
(a) |
Purchases and sales |
||||||
|
Class of relevant |
Purchase/sale |
Number of |
Price per unit |
||||
|
security |
securities |
||||||
|
5p ordinary |
Purchase |
56,812 |
2.8225 GBP |
||||
|
5p ordinary |
Purchase |
19,466 |
2.8200 GBP |
||||
|
5p ordinary |
Purchase |
12,296 |
2.8250 GBP |
||||
|
5p ordinary |
Purchase |
6,338 |
2.8222 GBP |
||||
|
5p ordinary |
Purchase |
3,542 |
2.8241 GBP |
||||
|
5p ordinary |
Purchase |
268 |
2.8251 GBP |
||||
|
5p ordinary |
Purchase |
70 |
2.8227 GBP |
||||
|
5p ordinary |
Sale |
43,009 |
2.8224 GBP |
||||
|
5p ordinary |
Sale |
29,353 |
2.8250 GBP |
||||
|
5p ordinary |
Sale |
14,734 |
2.8200 GBP |
||||
|
5p ordinary |
Sale |
8,498 |
2.8205 GBP |
||||
|
5p ordinary |
Sale |
8,286 |
2.8217 GBP |
||||
|
5p ordinary |
Sale |
7,859 |
2.8225 GBP |
||||
|
5p ordinary |
Sale |
354 |
2.8226 GBP |
||||
|
5p ordinary |
Sale |
99 |
2.8197 GBP |
||||
|
(b) |
Cash-settled derivative transactions |
||||||
|
Class of |
Product |
Nature of dealing |
Number of |
Price per |
|||
|
relevant |
description |
reference |
unit |
||||
|
security |
securities |
||||||
|
5p ordinary |
SWAP |
Increasing Long |
4,585 |
2.8200 GBP |
|||
|
5p ordinary |
SWAP |
Increasing Long |
99 |
2.8197 GBP |
|||
|
5p ordinary |
SWAP |
Increasing Long |
5,335 |
2.8197 GBP |
|||
|
5p ordinary |
SWAP |
Decreasing Long |
70 |
2.8226 GBP |
|||
|
5p ordinary |
SWAP |
Decreasing Long |
7,595 |
2.8238 GBP |
|||
|
5p ordinary |
SWAP |
Decreasing Long |
5,637 |
2.8238 GBP |
|||
|
5p ordinary |
SWAP |
Decreasing Long |
60 |
2.8238 GBP |
|||
|
5p ordinary |
SWAP |
Increasing Long |
2,951 |
2.8250 GBP |
|||
|
5p ordinary |
SWAP |
Decreasing Long |
268 |
2.8251 GBP |
|||
|
5p ordinary |
SWAP |
Increasing Long |
8,369 |
2.8200 GBP |
|||
|
(c) |
Stock-settled derivative transactions (including options) |
||||||
|
(i) |
Writing, selling, purchasing or varying |
||||||
|
Class |
Product |
Writing, |
Number |
Exercise |
Type |
Expiry |
Option |
|
of |
description |
purchasing, |
of |
price |
date |
money |
|
|
relevant |
selling, |
securities |
per unit |
paid/ |
|||
|
security |
varying etc |
to which |
received |
||||
|
option |
per unit |
||||||
|
relates |
|||||||
|
(ii) |
Exercise |
||||||
|
Class of relevant |
Product description |
Exercising/ exercised against |
Number of |
Exercise price per |
|||
|
security |
securities |
unit |
|||||
|
(d) |
Other dealings (including subscribing for new securities) |
||||||
|
Class of relevant |
Nature of Dealings |
Details |
Price per unit (if |
||||
|
security |
applicable) |
||||||
|
4. |
OTHER INFORMATION |
||||||
|
(a) |
Indemnity and other dealings arrangements |
||||||
|
Details of any indemnity or option arrangement, or any agreement or understanding, |
|||||||
|
formal or informal, relating to relevant securities which may be an inducement to deal |
|||||||
|
or refrain from dealing entered into by the exempt principal trader making the disclosure and any party |
|||||||
|
to the offer or any person acting in concert with a party to the offer: |
|||||||
|
NONE |
|||||||
|
(b) |
Agreements, arrangements or understandings relating to options or derivatives |
||||||
|
Details of any agreement, arrangement or understanding, formal or informal, between |
|||||||
|
the person making the disclosure and any other person relating to: |
|||||||
|
(i) the voting rights of any relevant securities under any option; or |
|||||||
|
(ii) the voting rights of future acquisition or disposal of any relevant securities to which |
|||||||
|
any derivative is referenced: |
|||||||
|
NONE |
|||||||
|
(c) |
Attachments |
||||||
|
Is a Supplemental Form 8 (Open Positions) attached? |
NO |
||||||
|
Date of disclosure: |
30 Sep 2026 |
||||||
|
Contact name: |
Large Holdings Regulatory Operations |
||||||
|
Telephone number: |
020 3134 7213 |
||||||